|
EP0851764A4
(en)
|
1995-08-18 |
2002-08-07 |
Sloan Kettering Inst Cancer |
VACCINE BASED ON HEAT SHOCK PROTEINS AND IMMUNOTHERAPIES
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6773707B1
(en)
|
1995-08-18 |
2004-08-10 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
US6017540A
(en)
*
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
DK1002110T3
(da)
|
1997-08-05 |
2003-05-26 |
Stressgen Biotechnologies Corp |
Immunsvar mod HPV-antigener fremkaldt af sammensætninger, som omfatter et HPV-antigen og et stressprotein eller en ekspressionsvektor i stand til at ekspressere disse proteiner
|
|
EP1336621B1
(en)
*
|
1997-08-05 |
2006-05-24 |
Stressgen Biotechnologies Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
AU2005201826B2
(en)
*
|
1997-08-05 |
2008-01-17 |
Nventa Biopharmaceuticals Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
US5948646A
(en)
*
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
AU757600B2
(en)
|
1998-02-20 |
2003-02-27 |
University Of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
US6797480B1
(en)
|
1998-10-05 |
2004-09-28 |
University Of Connecticut Health Center |
Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
US7378096B2
(en)
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
JP2003510334A
(ja)
|
1999-09-30 |
2003-03-18 |
コリクサ コーポレイション |
癌及び感染症の予防及び治療のためのストレスタンパク質組成物及び方法
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
JP2004505894A
(ja)
|
2000-06-02 |
2004-02-26 |
ユニバーシティー オブ コネティカット ヘルス センター |
免疫療法のためのα（２）マクログロブリンと抗原分子との複合体
|
|
WO2003015712A2
(en)
*
|
2001-08-20 |
2003-02-27 |
University Of Connecticut Health Center |
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin
|
|
CA2460396A1
(en)
|
2001-10-01 |
2003-04-10 |
Duke University |
Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
|
|
WO2003090686A2
(en)
*
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US7420037B2
(en)
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
AU2004213855B2
(en)
|
2003-02-20 |
2010-03-04 |
University Of Connecticut Health Center |
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
|
|
ES2395126T3
(es)
|
2003-02-28 |
2013-02-08 |
Agenus Inc. |
Uso de lectinas para promover la oligomerización de glicoproteínas y de moléculas antigénicas
|
|
US7309491B2
(en)
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
CA2538794C
(en)
*
|
2003-09-12 |
2016-04-19 |
Antigenics, Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
DK2257301T3
(da)
|
2008-03-03 |
2014-04-28 |
Univ Miami |
Immunterapi baseret på allogene cancerceller.
|
|
WO2009117116A2
(en)
|
2008-03-20 |
2009-09-24 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
|
CA2757524A1
(en)
|
2009-04-03 |
2010-10-07 |
Agenus Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
|
GB0910591D0
(en)
*
|
2009-06-19 |
2009-07-29 |
Immunobiology Ltd |
Method for the purification of protein complexes
|
|
GB0916557D0
(en)
|
2009-09-21 |
2009-10-28 |
Health Prot Agency |
Commensal neisserial stress protein complexes
|
|
ES2845727T3
(es)
|
2015-02-06 |
2021-07-27 |
Heat Biologics Inc |
Vector que coexpresa una vacuna y moléculas coestimuladoras
|
|
WO2016183486A1
(en)
|
2015-05-13 |
2016-11-17 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
|
US11666649B2
(en)
|
2016-10-11 |
2023-06-06 |
University Of Miami |
Vectors and vaccine cells for immunity against Zika virus
|
|
CA3058938A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
WO2019210055A2
(en)
|
2018-04-26 |
2019-10-31 |
Agenus Inc. |
Heat shock protein-binding peptide compositions and methods of use thereof
|